SREBP2 and SREBP2-dependent cholesterol biosynthesis are activated by c-Met/PI3K/AKT/mTOR axis in CRC, which allows CRC cells to undergo dynamic metabolic adjustments, facilitating adaptation to metastatic conditions (Zhang K. L. et al., 2021). The gene discussed is AKT1; the disease is colorectal carcinoma.